Percutaneous Radiofrequency Ablation of Hepatic Metastases for Symptomatic Relief of Neuroendocrine Syndromes

Henn, Adam R.; Levine, Edward A.; McNulty, William; Zagoria, Ronald J.

doi:10.2214/ajr.181.4.1811005

Cited by 82 publications

(44 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Various ablation techniques have been described, including cryoablation, alcohol ablation, and radiofrequency ablation (RFA) [120][121][122] . RFA involves conversion of radiofrequency waves to heat using a high alternating current that causes ionic vibration after the change in the current direction.…”

Section: Radiofrequency Ablationmentioning

confidence: 99%

ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors

et al. 2012

View full text Add to dashboard Cite

Section: Radiofrequency Ablationmentioning

confidence: 99%

ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors

et al. 2012

View full text Add to dashboard Cite

“…Three reports present the results of RFA for neuroendocrine liver metastases [48,49,50]. Symptomatic relief after RFA was obtained in about 70% of the patients [49, 50].…”

Section: Resultsmentioning

confidence: 99%

“…Symptomatic relief after RFA was obtained in about 70% of the patients [49, 50]. Furthermore, the complication rate using the minimally invasive approach of either laparoscopy or percutaneous ablation was remarkably low [49, 50].…”

Section: Resultsmentioning

confidence: 99%

Radiofrequency for the Treatment of Liver Tumours

2005

View full text Add to dashboard Cite

Resection should still be considered the gold standard for many liver tumours. There is, however, growing interest in the use of radiofrequency (RFA) for the treatment of liver tumours. By RFA, tumour tissue can be destructed selectively without significant damage to vascular structures in the remaining liver. The technique is safe and feasible for many types of liver tumours. RFA appears to be beneficial in the treatment of hepatocellular carcinoma. In the Netherlands, single-centre reports suggest that RFA may be used successfully to control hepatocellular carcinoma in those patients awaiting liver transplantation. RFA is being increasingly used for colorectal liver metastases as an adjunct to surgical resection in case of unresectable lesions. However, to date, there are still no data showing that such an approach is beneficial. For this reason, in the Netherlands, RFA for unresectable colorectal liver metastases is mainly used within a clinical trial. Within the multimodality treatment of neuroendocrine metastases, RFA may deserve a place for either intention to cure (rare) or debulking with the aim of reduction of symptoms or prolongation of life.

show abstract

“…Furthermore, the role of multivisceral transplantation is evolving for neuroendocrine tumors [11]. Cryosurgery and radiofrequency ablation have been described for control of metastatic disease, although none of our patients underwent these treatment modalities [12,13].…”

Section: Discussionmentioning

confidence: 99%

Surgery in malignant pancreatic neuroendocrine tumors

Nguyen

Angel

Divino

et al. 2007

Journal of Surgical Oncology

View full text Add to dashboard Cite

show abstract

Percutaneous Radiofrequency Ablation of Hepatic Metastases for Symptomatic Relief of Neuroendocrine Syndromes

Abstract: Percutaneous radiofrequency ablation, a minimally invasive technique, is an effective and safe way to reduce systemic symptoms in patients with hepatic metastases from neuroendocrine neoplasms.

Cited by 82 publications

References 12 publications

ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors

ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors

Radiofrequency for the Treatment of Liver Tumours

Surgery in malignant pancreatic neuroendocrine tumors

Contact Info

Product

Resources

About